These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28107378)

  • 21. Association of PTPN22 (rs2476601) and STAT4 (rs7574865) polymorphisms with Rheumatoid Arthritis in the Western Algerian population.
    Fodil M; Benzaoui A; Zemani-Fodil F; Aberkane M; Boughrara W; Saidi-Mehtar N; Petit-Teixeira E; Boudjema A
    Acta Reumatol Port; 2015; 40(1):56-62. PubMed ID: 25351936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: a meta-analysis.
    Tong G; Zhang X; Tong W; Liu Y
    Hum Immunol; 2013 May; 74(5):586-92. PubMed ID: 23295549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal transducer and activator of transcription 4 gene polymorphisms associated with rheumatoid arthritis in Northwestern Chinese Han population.
    Liang YL; Wu H; Li PQ; Xie XD; Shen X; Yang XQ; Cheng X; Liang L
    Life Sci; 2011 Aug; 89(5-6):171-5. PubMed ID: 21683716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
    Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.
    Dávila-Fajardo CL; van der Straaten T; Baak-Pablo R; Medarde Caballero C; Cabeza Barrera J; Huizinga TW; Guchelaar HJ; Swen JJ
    Pharmacogenomics; 2015; 16(4):373-81. PubMed ID: 25823785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.
    Zervou MI; Sidiropoulos P; Petraki E; Vazgiourakis V; Krasoudaki E; Raptopoulou A; Kritikos H; Choustoulaki E; Boumpas DT; Goulielmos GN
    Hum Immunol; 2008 Sep; 69(9):567-71. PubMed ID: 18625278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.
    Palomino-Morales R; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Rodriguez L; Miranda-Filloy JA; Pascual-Salcedo D; Balsa A; Fernandez-Gutierrez B; Llorca J; Martin J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2010; 28(5):695-701. PubMed ID: 20822712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal transducer and activator of transcription 4 (STAT4) G>T gene polymorphism in Egyptian cases with rheumatoid arthritis.
    Settin A; Salama A; Elshazli R
    Hum Immunol; 2014 Aug; 75(8):863-6. PubMed ID: 24979672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations.
    Orozco G; Alizadeh BZ; Delgado-Vega AM; González-Gay MA; Balsa A; Pascual-Salcedo D; Fernández-Gutierrez B; González-Escribano MF; Petersson IF; van Riel PL; Barrera P; Coenen MJ; Radstake TR; van Leeuwen MA; Wijmenga C; Koeleman BP; Alarcón-Riquelme M; Martín J
    Arthritis Rheum; 2008 Jul; 58(7):1974-80. PubMed ID: 18576336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders.
    Ben Hamad M; Cornelis F; Mbarek H; Chabchoub G; Marzouk S; Bahloul Z; Rebai A; Fakhfakh F; Ayadi H; Petit-Teixeira E; Maalej A
    Clin Exp Rheumatol; 2011; 29(2):269-74. PubMed ID: 21418779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis.
    Tao W; Concepcion AN; Vianen M; Marijnissen ACA; Lafeber FPGJ; Radstake TRDJ; Pandit A
    Arthritis Rheumatol; 2021 Feb; 73(2):212-222. PubMed ID: 32909363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt.
    Romão VC; Santos MJ; Polido-Pereira J; Duarte C; Nero P; Miguel C; Costa JA; Bernardes M; Pimentel-Santos FM; Barcelos F; Costa L; Melo Gomes JA; Pereira da Silva JA; Cunha Branco J; Canas da Silva J; Pereira da Silva JA; Fonseca JE; Canhão H
    Biomed Res Int; 2015; 2015():279890. PubMed ID: 26000286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of association between the TRAF family genes and RA susceptibility.
    Potter C; Eyre S; Cope A; Worthington J; Barton A
    Ann Rheum Dis; 2007 Oct; 66(10):1322-6. PubMed ID: 17277003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSORS1C1 may be involved in rheumatoid arthritis.
    Sun H; Xia Y; Wang L; Wang Y; Chang X
    Immunol Lett; 2013 Jun; 153(1-2):9-14. PubMed ID: 23769905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis.
    Daïen CI; Fabre S; Rittore C; Soler S; Daïen V; Tejedor G; Cadart D; Molinari N; Daurès JP; Jorgensen C; Touitou I
    Joint Bone Spine; 2012 Oct; 79(5):471-5. PubMed ID: 22129793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
    Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
    Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis.
    Krintel SB; Palermo G; Johansen JS; Germer S; Essioux L; Benayed R; Badi L; Ostergaard M; Hetland ML
    Pharmacogenet Genomics; 2012 Aug; 22(8):577-89. PubMed ID: 22569225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors.
    Biggioggero M; Mesina F; Favalli EG
    Biomed Res Int; 2019; 2019():6107217. PubMed ID: 30733963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
    Remmers EF; Plenge RM; Lee AT; Graham RR; Hom G; Behrens TW; de Bakker PI; Le JM; Lee HS; Batliwalla F; Li W; Masters SL; Booty MG; Carulli JP; Padyukov L; Alfredsson L; Klareskog L; Chen WV; Amos CI; Criswell LA; Seldin MF; Kastner DL; Gregersen PK
    N Engl J Med; 2007 Sep; 357(10):977-86. PubMed ID: 17804842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.